Alkermes Plc - Company Profile
Powered by 
All the sales intelligence you need on Alkermes Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Alkermes Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Alkermes Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Alkermes Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Alkermes Plc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Richard F. Pops
Chairman; Chief Executive Officer Executive BoardMr. Richard F. Pops has been the Chairman and Chief Executive Officer of the company since 2011. He currently serves as the Director of Neurocrine Biosciences, Inc. Prior to this, he served in Director roles in various companies, including Acceleron Pharma Inc from 2004 to December 2019, Epizyme Inc from 2008 to October 2020, and the National Health Council from 2016 to December 2019.
Joshua Reed
Chief Financial Officer Senior ManagementMr. Joshua Reed has been the Chief Financial Officer of the company since September 2025. Previously, he was the Chief Financial Officer of Omega Therapeutics. Prior ot this, he served as Chief Financial Officer of Aldeyra Therapeutics. Prior to that, he was the Vice President and Head of Finance Operations for the U.S. and Puerto Rico at Bristol Myers Squibb. Mr. Reed worked at JPMorganChase, Credit Suisse First Boston, and Chase Manhattan Bank.
Blair C. Jackson
Chief Risk Officer; Chief Operating Officer; Executive Vice President Senior ManagementMr. Blair C. Jackson has been the Executive Vice President, Chief Risk Officer, Interim Principal Financial Officer, and Chief Operating Officer of the company since 2024. Prior to this, he served as the Senior Vice President of Corporate Planning of the company since 2018; Senior Vice President of Business Development since 2016; and Vice President of Business Development since 2006.
Tom Skoff
Chief Information Officer; Senior Vice President Senior ManagementMr. Tom Skoff is the Chief Information Officer and Senior Vice President of the company. Prior to this, he served as Vice President of Information Technology (IT) of Mural Oncology from 2023 to 2025.
David J. Gaffin
Executive Vice President; Secretary; Chief Legal Officer; Chief Compliance Officer Senior ManagementMr. David J. Gaffin is the Executive Vice President, Chief Compliance Officer, Chief Legal Officer and Secretary of the company since 2022. Prior to this, he served as the Vice President of the US General Counsel of the company from 2014 to 2016. Previously, he served as the President of the US General Counsel from 2011 to 2014. Mr. Gaffin also served as the Assistant General Counsel at Biogen Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer